CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy

BACKGROUND: Cancerous inhibitor of protein phosphatase 2A (CIP2A) plays a critical role in the pathogenesis of various types of cancer. Here, we investigated whether manipulating CIP2A abundance could enhance the treatment effects of doxorubicin in MCF-7/ADR cells. METHODS: CIP2A silencing was achie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Z., Wei, Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238779/
https://www.ncbi.nlm.nih.gov/pubmed/33948919
http://dx.doi.org/10.1007/s12094-021-02616-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238779/
https://www.ncbi.nlm.nih.gov/pubmed/33948919
http://dx.doi.org/10.1007/s12094-021-02616-7

Ejemplares similares